{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:33:28Z","timestamp":1772134408320,"version":"3.50.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T00:00:00Z","timestamp":1507161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K99 AI110645"],"award-info":[{"award-number":["K99 AI110645"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"crossref","award":["H2020-MSCA-IF-2014 656086"],"award-info":[{"award-number":["H2020-MSCA-IF-2014 656086"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian Science Fund","award":["J3399-B21"],"award-info":[{"award-number":["J3399-B21"]}]},{"name":"Pasteur - Paris University (PPU) International Ph.D. Program"},{"name":"Stanford NIH\/NCRR CTSA award","award":["UL1 RR025744"],"award-info":[{"award-number":["UL1 RR025744"]}]},{"name":"Fondation pour la Recherche M\u00e9dicale (FR)"},{"name":"George Will Foundation"},{"name":"Chambers Family Foundation Fund for Excellence in Pediatric Research"},{"name":"Child Health Research Institute at Stanford"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI104209"],"award-info":[{"award-number":["U19 AI104209"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR067145"],"award-info":[{"award-number":["AR067145"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS 080062"],"award-info":[{"award-number":["NS 080062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0185704","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T17:43:32Z","timestamp":1507225412000},"page":"e0185704","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["The tyrosine kinase inhibitor imatinib mesylate suppresses uric acid crystal-induced acute gouty arthritis in mice"],"prefix":"10.1371","volume":"12","author":[{"given":"Laurent L.","family":"Reber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Starkl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Balbino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Sibilano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Gaudenzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Rogalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Sensarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Raghu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Sokolove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Contag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mindy","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-5340","authenticated-orcid":true,"given":"Stephen J.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,10,5]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Y Zhu","year":"2011","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/BOR.0b013e3282f4eff5","article-title":"Refractory gout: what is it and what to do about it?","volume":"20","author":"E Fels","year":"2008","journal-title":"Current opinion in rheumatology"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2165\/11592290-000000000-00000","article-title":"Difficult-to-treat gouty arthritis: a disease warranting better management","volume":"71","author":"N Schlesinger","year":"2011","journal-title":"Drugs"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"A So","year":"2007","journal-title":"Arthritis research & therapy"},{"key":"ref5","unstructured":"Committee FA. Summary Minutes of the Arthritis Advisory Committee Meeting June 21, 2011. 2011."},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1172\/JCI28546.","article-title":"Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis","volume":"116","author":"RT Paniagua","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/07853890310001339","article-title":"Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases","volume":"35","author":"KK Eklund","year":"2003","journal-title":"Ann Med"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/ard.2004.029835","article-title":"Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis","volume":"64","author":"A Juurikivi","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4\u20135","key":"ref9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10067-003-0716-3","article-title":"Efficacy of imatinib mesylate (STI571) treatment for a patient with rheumatoid arthritis developing chronic myelogenous leukemia","volume":"22","author":"K Miyachi","year":"2003","journal-title":"Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-pharmtox-011112-140341","article-title":"Tyrosine kinase inhibitors: views of selectivity, sensitivity, and clinical performance","volume":"53","author":"A Levitzki","year":"2013","journal-title":"Annual review of pharmacology and toxicology"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/art.38747","article-title":"Contribution of mast cell-derived interleukin-1beta to uric Acid crystal-induced acute arthritis in mice","volume":"66","author":"LL Reber","year":"2014","journal-title":"Arthritis & rheumatology"},{"issue":"7081","key":"ref12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"F Martinon","year":"2006","journal-title":"Nature"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nm.1886","article-title":"Bioluminescence imaging of myeloperoxidase activity in vivo","volume":"15","author":"S Gross","year":"2009","journal-title":"Nature medicine"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni.1878","article-title":"Synaptotagmin-mediated vesicle fusion regulates cell migration","volume":"11","author":"RA Colvin","year":"2010","journal-title":"Nat Immunol"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00281-013-0361-0","article-title":"Neutrophils, IL-1beta, and gout: is there a link?","volume":"35","author":"I Mitroulis","year":"2013","journal-title":"Seminars in immunopathology"},{"issue":"12","key":"ref16","first-page":"2320","article-title":"Not water, but formalin, dissolves urate crystals in tophaceous tissue samples","volume":"21","author":"PA Simkin","year":"1994","journal-title":"J Rheumatol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms","volume":"22","author":"Y Zermati","year":"2003","journal-title":"Oncogene"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"BJ Druker","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-0957-03","article-title":"Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer","volume":"10","author":"NC Wolff","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard.2004.030759","article-title":"Treatment of experimental arthritis with poly(D, L-lactic\/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate","volume":"64","author":"M Higaki","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/art.10198","article-title":"Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance","volume":"46","author":"WU Kim","year":"2002","journal-title":"Arthritis and rheumatism"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.leukres.2013.01.021","article-title":"Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors","volume":"37","author":"M Breccia","year":"2013","journal-title":"Leuk Res"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4155\/tde.14.91","article-title":"PLGA: a unique polymer for drug delivery","volume":"6","author":"DN Kapoor","year":"2015","journal-title":"Ther Deliv"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0185704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T18:58:07Z","timestamp":1588964287000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0185704"}},"subtitle":[],"editor":[{"given":"Valentin","family":"Ce\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,5]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0185704","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,5]]}}}